Written question asked by Tom Harris (Labour) on Monday, 16 December 2002, in the House of Commons. It was due for an answer on Tuesday, 17 December 2002. It was answered by Patricia Hewitt (Labour) on Tuesday, 17 December 2002 on behalf of the Department of Trade and Industry.
Dept of Trade and Industry
- Question
- To ask the Secretary of State for Trade and Industry, what steps the Government has taken to protect medical research companies against the actions of animal rights activists.
- Answer
-
Mr. Tom Harris: To ask the Secretary of State for Trade and Industry, what steps the Government have taken to protect medical research companies against the actions of animal rights activists. [87984] Ms Hewitt: The Government are determined that animal rights extremists will not prevent companies carrying out legitimate business in the UK and that these companies will be protected from intimidation and harassment. In recognition of the exceptional circumstances Huntingdon Life Sciences Group plc have found themselves in, the DTI has previously agreed to provide banking facilities for Huntingdon Life Sciences Group plc. The DTI is now extending its support to facilitate the provision of insurance services to Huntingdon Life Sciences Group plc on a worldwide basis. Both these actions have been taken to secure Huntingdon Life Sciences Group plc from the harm caused by the criminal intimidation and assault being directed at its employees, including their families and friends, and also those of its suppliers, customers and other companies. Huntingdon Life Sciences Group plc is a world-leading provider in the highly regulated area of essential research, development and toxicological testing services for the pharmaceutical, biotechnology and chemical industries. Any commercial damage to these industries or their supporting services, like Huntingdon Life Sciences, would have a very serious impact on UK scientific and medical research. The DTI is not using commercial insurance companies or brokers at this time and is providing insurance through its own resources.
Secondary information
- Type
- Written question
- Reference
- 87984; 396 c733-4W;396 c733W
- Session
- 2002-03
- Subjects
- Bullying Animal welfare Companies Animal experiments Protection Protest Medicine Research Huntingdon Life Sciences
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2016-10-06 09:45:38 +0100
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_710784
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_710784
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_710784